EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Dyslipidemia accelerates prostate volume enlargement in middle-aged Chinese men: a prospective cohort study focusing on lipid ratios

Yang Li, Zhuo Yin, Chu-Qi Wen, Xiang-Yang Li

Asian Journal of Andrology · 2026-11 · 28 (6) · 886-892

DOI: 10.4103/aja202624 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Asian Journal of Andrology, online erschienen am 01.09.2026. Verfasst von Yang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Xiangya Hospital of Central South University, Changsha 410011, China. Hauptthemen laut MEDLINE: Dyslipidemias, Prostatic Hyperplasia, Prostate. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This prospective cohort study investigated the association between dyslipidemia and prostate volume progression in middle-aged Chinese men. A total of 5607 men aged >40 years at The Second Xiangya Hospital of Central South University (Changsha, China), between January 2020 and January 2023, who did not have baseline benign prostatic hyperplasia, were followed for three years. Participants were categorized by their baseline lipid status according to Chinese guidelines. Prostate volume was measured annually, using transrectal ultrasound, with enlargement defined as a volume of ≥31 ml. The results showed that 48.0% of men with dyslipidemia developed prostatic enlargement, compared to 36.5% with normal lipid levels. Elevated ratios of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol and total cholesterol to high-density lipoprotein cholesterol were significantly associated with an increased risk in a dose–response manner. This association was independent of age, body mass index, and fasting glucose levels. High-density lipoprotein cholesterol demonstrated a protective effect. These findings suggest that dyslipidemia, particularly as reflected in specific lipid ratios, is an independent and modifiable risk factor for accelerated prostatic enlargement. This indicates that lipid assessment could be valuable for early risk stratification and prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyslipidemiasProstatic HyperplasiaProstateHumansMaleMiddle AgedProspective StudiesOrgan SizeChinaCholesterol, HDLRisk FactorsCholesterol, LDLLipidsCholesterolDisease Progression

Stichwörter der Autor:innen

cohort studiesdyslipidemiaslipidsprostate volumeprostatic hyperplasiarisk factors

Substanzen

Cholesterol, HDLCholesterol, LDLLipidsCholesterol

Autor:innen und Institutionen

  • Department of Urology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
  • Chengdu Wuhou District Medical Security Affairs Center, Chengdu 610041, China.
  • Shenzhen Health Capacity Building and Continuing Education Center, Shenzhen 518200, China.

Zitieren

APA

Li, Y., Yin, Z., Wen, C. Q., & Li, X. Y. (2026). Dyslipidemia accelerates prostate volume enlargement in middle-aged Chinese men: a prospective cohort study focusing on lipid ratios. Asian Journal of Andrology, 28(6), 886-892. https://doi.org/10.4103/aja202624

Vancouver

Li Y, Yin Z, Wen CQ, Li XY. Dyslipidemia accelerates prostate volume enlargement in middle-aged Chinese men: a prospective cohort study focusing on lipid ratios. Asian Journal of Andrology. 2026;28(6):886-892. doi:10.4103/aja202624

BibTeX
@article{Li2026,
  author = {Li, Yang and Yin, Zhuo and Wen, Chu-Qi and Li, Xiang-Yang},
  title = {Dyslipidemia accelerates prostate volume enlargement in middle-aged Chinese men: a prospective cohort study focusing on lipid ratios},
  journal = {Asian Journal of Andrology},
  year = {2026},
  volume = {28},
  number = {6},
  pages = {886--892},
  doi = {10.4103/aja202624}
}
Kostenlos starten →